Abiopharma

🔍 GUTHART GARY S (Director)

Company: INTUITIVE SURGICAL INC (ISRG)

Report Date: 2026-02-10

Detailed Transactions and Holdings:

• Acquired 2,633 shares of Common Stock (Direct)
  Date: 2026-02-10 | Code: M | equity_swap_involved: 0 | shares_owned_after: 6,327.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 1,306 shares of Common Stock at $492.84 per share (Direct)
  Date: 2026-02-10 | Code: F | equity_swap_involved: 0 | shares_owned_after: 5,021.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-02-10 | Code: H | nature_of_ownership: Trust FBO Daughter | shares_owned_after: 15,720.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-02-10 | Code: H | nature_of_ownership: Trust FBO Son | shares_owned_after: 15,720.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-02-10 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 1,231,890.00
• Sold 2,633 shares of Restricted Stock Units (Derivative)
  Date: 2026-02-10 | Code: M | equity_swap_involved: 0 | shares_owned_after: 2,633.00 | transaction_form_type: 4 | Footnotes: F2, F2

Footnotes:

• F1: RSUs vest 25% per year over a four year period, commencing on each anniversary of February 10, 2023. RSUs convert into common stock on the vest date on a one-for-one basis. 25% of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.
• F2: Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock upon vesting. 25% of the RSUs shall vest on each anniversary of February 10, 2023, subject to Reporting Person's continuous service to the Issuer through each such vesting date.